Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme

British Journal of Cancer

Volumn 107, Issue 3, 2012, Pages 417-421

  Gill, M D ^a,b,c   Bramble, M G ^b,c   Rees, C J ^b,c   Lee, T J W ^b,d   Bradburn, D M ^a   Mills, S J ^a  

^a NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^b Northern Region Endoscopy Group   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

colonoscopy; colorectal cancer; colorectal neoplasm; screening

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BOWEL CANCER SCREENING PROGRAMME; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FECAL OCCULT BLOOD TESTING; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL HEALTH SERVICE; OCCULT BLOOD TEST; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; SURVIVAL RATE;

EID: 84864332670     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.305     Document Type: Article

References (17)

1. Arain MA, Sawhney M, Sheikh S, Anway R, Thyagarajan B, Bond JH, Shaukat A (2010) CIMP Status of interval colon cancers: another piece to the puzzle. Am J of Gastroenterol 105(5): 1189-1195
2. Cancer Research UK (2010) Bowel (colorectal) cancer-UK incidence statistics. Available from: http://info.cancerresearchuk.org/cancerstats/types/ bowel/incidence/#source20
3. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350(10): 991-1004
4. Dray X, Camus M, Coelho J, Ozenne V, Pocard M, Marteau P (2011) Treatment of gastrointestinal angiodysplasia and unmet needs. Dig Liver Dis 43(7): 515-522
5. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C (2004) Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126(7): 1674-1680
6. Hardcastle J, Chamberlain J, Robinson M, Moss S, Amar S, Balfour T, James P, Mangham C (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348(9040): 1472-1477
7. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C (1994) Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 29(5): 468-473
8. Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occultblood test. Lancet 348(9040): 1467-1471
9. Kronborg O, Fenger C, Sondergaard O, Pedersen KM, Olsen J (1987) Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol 22(6): 677-686
10. Lee T, Rutter M, Blanks R, Moss S, Goddard A, Chilton A, Nickerson C, McNally R, Patnick J, Rees C (2012a) Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 61(7): 1050-1057
11. Lee TJ, Clifford GM, Hull MA, Ritchie M, James P, McNally RJ, Rutter MD, Rees CJ (2012b) Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing? Digestion 85(4): 278-281
12. Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91(5): 434-437
13. National Bowel Cancer Audit Project (2011) National Bowel Cancer Audit Annual Report 2010. Document Ref: IC18050111. Available from: http://www.ic.nhs.uk/webfiles/Services/NCASP/audits%20and%20reports/ NHS-Bowel-Cancer-2010-INTERACTIVE.pdf
14. Pokoradi AJ, Iversen L, Hannaford PC (2011) Factors associated with age of onset and type of menopause in a cohort of UK women. Am J Obstet Gynecol 205(1): 34.e1-34.e13
15. Rees C, Rutter M (2010) NREG: old banger or new vehicle for research? Frontline Gastroenterol 1(1): 59-62
16. Sawhney M, Farrar W, Gudiseva S, Nelson D, Lederle F, Rector T, Bond J (2006) Microsatellite instability in interval colon cancers. Gastroenterology 131(6): 1700-1705
17. Steele RJC, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser CG (2012) Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 61(4): 576-581